Clinical Trial Update: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an oral switch strategy during treatment for left-sided infective endocarditis caused by multi-susceptible Streptococcus has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infective Endocarditis

Snippet

Sponsor: University Hospital, Tours | Conditions: Infective Endocarditis | Phase 3 | Status: COMPLETED